Ara
Toplam kayıt 5, listelenen: 1-5
Treatment Outcomes of Breast Cancer Liver Metastasis Treated with Stereotactic Body Radiotherapy
(2018)
Background: To assess the outcomes of breast cancer liver metastasis (BCLM) treated with stereotactic body radiotherapy (SBRT) and systemic treatment.
Materials and methods: Patients with oligometastasis at the time of ...
Prognostic Value of Metabolic Response Measured by FDG-PET-CT in Patients with Breast Cancer Liver Metastasis Treated with Stereotactic Body Radiotherapy
(2018)
OBJECTIVE
To investigate the impact of metabolic response measured by 18-fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET-CT) in patients with breast cancer liver metastasis (BCLM) treated ...
The use of 18F-FDG positron emission tomography to detect mediastinal lymph nodes in metastatic breast cancer
(2020)
Background: To assess the predictive value of F-18-fluorodeoxyglucose positron-emission tomography (FDG-PET/CT) in detecting mediastinal lymph node metastasis with histopathologic verification in breast cancer (BC) ...
Radiotherapy After Skin-Sparing Mastectomy and Implant-Based Breast Reconstruction
(2019)
We aimed to evaluate the cosmetic results of radiotherapy in 170 breast cancer patients after implant-based reconstruction. Cosmetic results were excellent or fair in most patients after radiotherapy. However, bolus use, ...
Significance of liver metastasis volume in breast cancer patients treated with stereotactic body radiotherapy
(2021)
Purpose This study analyzed the impact of liver metastasis (LM) volume on treatment outcomes in breast cancer (BC) patients treated with stereotactic body radiotherapy (SBRT). Methods This single-institution retrospective ...